Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT06623461 - Immune checkpoint inhibitors (ICIs) vs Fecal Microbiota Transplantation (FMT) + Immune checkpoint inhibitors (ICIs) & Melanoma (cutaneous)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

It is a randomized, clinical phase II treatment trial studying Immune checkpoint inhibitors (ICIs) vs Immune checkpoint inhibitors (ICIs) + Fecal Microbiota Transplantation (FMT) in patients with Melanoma (cutaneous) (stage IV or advanced unresectable disease). Fecal Microbiota Transplantation (FMT) is named LND101.

Primary outcome measures

Progression-free survival (PFS)

Results

No published results were found as of May 2026

…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!